Abstract Details

Title 30-Day Risk-Standardized Mortality and Readmission after Hemorrhagic Stroke in Hospitals with and without a JC-Certified Primary Stroke Center

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Judy H. Lichtman, PhD, MPH (Yale University)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Larry B. Goldstein, MD, FAHA, FAAN (University of Kentucky)	The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Mark Gorman, MD	The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .

��ɫ��